Universitätsklinikum Heidelberg

Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT (2022) Engler T, Fasching P, Lueftner D, Hartkopf AD, Mueller V, Kolberg HC, Hadji P, et al. Journal article Impact of off-label use regulations on patient care in dermatology – a prospective study of cost-coverage applications filed by tertiary dermatology clinics throughout Germany (2022) Werner RN, Pennitz A, Eisert L, Schmidle P, Zink A, Abraham S, Schaekel K, et al. Journal article Generalized pustular psoriasis: overview of the status quo and results of a panel discussion (2022) Reich K, Augustin M, Gerdes S, Ghoreschi K, Kokolakis G, Mößner R, Mrowietz U, et al. Journal article, Review article Trophoblast Cell Surface Antigen 2 (Trop2) in Chromophobe Renal Cell Carcinoma (2022) Mikuteit M, Steffens S, Zschäbitz S, Autenrieth M, Weichert W, Hartmann A, Erlmeier F Journal article Whole-body magnetic resonance imaging plus serological follow-up for early identification of progression in smouldering myeloma patients to prevent development of end-organ damage (2022) Wennmann M, Goldschmidt H, Mosebach J, Hielscher T, Bäuerle T, Komljenovic D, Mccarthy PL, et al. Journal article Sex chromosome DSD individuals with mosaic 45,X0 and aberrant Y chromosomes in 46,XY cells: distinct gender phenotypes and germ cell tumour risks§ (2022) Vogt PH, Besikoglu B, Bettendorf M, Frank-Herrmann P, Zimmer J, Bender U, Knauer-Fischer S, et al. Journal article CAD-RADS Scoring using Deep Learning and Task-Specific Centerline Labeling (2022) Denzinger F, Wels M, Taubmann O, Gülsün MA, Schöbinger M, Andre F, Buss SJ, et al. Conference contribution Real World Evidence on the comparative effectiveness of Ustekinumab vs anti-TNF in Crohn's disease with Propensity Score adjustment: maintenance phase results from the prospective observational RUN-CD study (2022) Bokemeyer B, Plachta-Danielzik S, Di Giuseppe R, Deppe H, Mohl W, Teich N, Hoffstadt M, et al. Conference contribution Comparative real-world effectiveness and persistence of vedolizumab versus anti-TNF therapy in biologic-naive patients with Crohn's Disease with Propensity Score adjustment: Maintenance phase results at week-52 from the prospective VEDOIBD study (2022) Di Giuseppe R, Plachta-Danielzik S, Bokemeyer B, Efken P, Mohl W, Hoffstadt M, Krause T, et al. Conference contribution Caspase-8 in endothelial cells maintains gut homeostasis and prevents small bowel inflammation in mice (2022) Tisch N, Mogler C, Stojanovic A, Luck R, Korhonen EA, Ellerkmann A, Adler H, et al. Journal article